Δ9-Tetrahydrocannabinol decreases turnover of brain histamine

R. Oishi, Y. Itoh, Masahiro Nishibori, K. Saeki

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Histamine (HA) is a neurotransmitter present in the brain. As there is little information on the effect of Δ9-tetrahydrocannabinol (Δ9-THC) on brain histaminergic activity, the possible Δ9-THC-induced changes in brain HA turnover were studied in rats and mice. Whereas various doses of Δ9-THC had no influence on the brain HA levels in these species, high doses of Δ9-THC reduced the content of tele-methylhistamine (t-MH), a predominant HA metabolite in the brain, in mice. A moderate dose of Δ9-THC was effective in decreasing the brain t-MH content in the rats. Pargyline (65 mg/kg i.p.) caused a 101 ng/g accumulation of t-MH in mice and an 80 ng/g accumulation of t-MH in rats 105 min after the injection. Δ9-THC significantly suppressed the pargyline-induced t-MH accumulation at 50 mg/kg in mice whereas only 2 mg/kg of this compound was effective in rats, when administered i.v. 15 min after pargyline treatment. Δ9-THC (50 mg/kg i.v.) delayed the depletion of neuronal HA in the mouse brain, as induced by treatment with a specific histidine decarboxylase inhibitor α-fluoromethylhistidine (50 mg/kg i.p.). Δ9-THC (30 and 100 μM) significantly inhibited the K+-induced release of endogenous HA from guinea-pig hypothalamic slices. These results suggest that Δ9-THC decreases HA turnover in the brain.

Original languageEnglish
Pages (from-to)513-518
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume232
Issue number2
Publication statusPublished - 1985

Fingerprint

Dronabinol
Histamine
Brain
Pargyline
Histidine Decarboxylase
Histamine Release
Neurotransmitter Agents
Guinea Pigs
tele-methylhistamine
Injections

ASJC Scopus subject areas

  • Pharmacology

Cite this

Δ9-Tetrahydrocannabinol decreases turnover of brain histamine. / Oishi, R.; Itoh, Y.; Nishibori, Masahiro; Saeki, K.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 232, No. 2, 1985, p. 513-518.

Research output: Contribution to journalArticle

@article{4134f36b6df4428fbf4e3c3e8f64913f,
title = "Δ9-Tetrahydrocannabinol decreases turnover of brain histamine",
abstract = "Histamine (HA) is a neurotransmitter present in the brain. As there is little information on the effect of Δ9-tetrahydrocannabinol (Δ9-THC) on brain histaminergic activity, the possible Δ9-THC-induced changes in brain HA turnover were studied in rats and mice. Whereas various doses of Δ9-THC had no influence on the brain HA levels in these species, high doses of Δ9-THC reduced the content of tele-methylhistamine (t-MH), a predominant HA metabolite in the brain, in mice. A moderate dose of Δ9-THC was effective in decreasing the brain t-MH content in the rats. Pargyline (65 mg/kg i.p.) caused a 101 ng/g accumulation of t-MH in mice and an 80 ng/g accumulation of t-MH in rats 105 min after the injection. Δ9-THC significantly suppressed the pargyline-induced t-MH accumulation at 50 mg/kg in mice whereas only 2 mg/kg of this compound was effective in rats, when administered i.v. 15 min after pargyline treatment. Δ9-THC (50 mg/kg i.v.) delayed the depletion of neuronal HA in the mouse brain, as induced by treatment with a specific histidine decarboxylase inhibitor α-fluoromethylhistidine (50 mg/kg i.p.). Δ9-THC (30 and 100 μM) significantly inhibited the K+-induced release of endogenous HA from guinea-pig hypothalamic slices. These results suggest that Δ9-THC decreases HA turnover in the brain.",
author = "R. Oishi and Y. Itoh and Masahiro Nishibori and K. Saeki",
year = "1985",
language = "English",
volume = "232",
pages = "513--518",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Δ9-Tetrahydrocannabinol decreases turnover of brain histamine

AU - Oishi, R.

AU - Itoh, Y.

AU - Nishibori, Masahiro

AU - Saeki, K.

PY - 1985

Y1 - 1985

N2 - Histamine (HA) is a neurotransmitter present in the brain. As there is little information on the effect of Δ9-tetrahydrocannabinol (Δ9-THC) on brain histaminergic activity, the possible Δ9-THC-induced changes in brain HA turnover were studied in rats and mice. Whereas various doses of Δ9-THC had no influence on the brain HA levels in these species, high doses of Δ9-THC reduced the content of tele-methylhistamine (t-MH), a predominant HA metabolite in the brain, in mice. A moderate dose of Δ9-THC was effective in decreasing the brain t-MH content in the rats. Pargyline (65 mg/kg i.p.) caused a 101 ng/g accumulation of t-MH in mice and an 80 ng/g accumulation of t-MH in rats 105 min after the injection. Δ9-THC significantly suppressed the pargyline-induced t-MH accumulation at 50 mg/kg in mice whereas only 2 mg/kg of this compound was effective in rats, when administered i.v. 15 min after pargyline treatment. Δ9-THC (50 mg/kg i.v.) delayed the depletion of neuronal HA in the mouse brain, as induced by treatment with a specific histidine decarboxylase inhibitor α-fluoromethylhistidine (50 mg/kg i.p.). Δ9-THC (30 and 100 μM) significantly inhibited the K+-induced release of endogenous HA from guinea-pig hypothalamic slices. These results suggest that Δ9-THC decreases HA turnover in the brain.

AB - Histamine (HA) is a neurotransmitter present in the brain. As there is little information on the effect of Δ9-tetrahydrocannabinol (Δ9-THC) on brain histaminergic activity, the possible Δ9-THC-induced changes in brain HA turnover were studied in rats and mice. Whereas various doses of Δ9-THC had no influence on the brain HA levels in these species, high doses of Δ9-THC reduced the content of tele-methylhistamine (t-MH), a predominant HA metabolite in the brain, in mice. A moderate dose of Δ9-THC was effective in decreasing the brain t-MH content in the rats. Pargyline (65 mg/kg i.p.) caused a 101 ng/g accumulation of t-MH in mice and an 80 ng/g accumulation of t-MH in rats 105 min after the injection. Δ9-THC significantly suppressed the pargyline-induced t-MH accumulation at 50 mg/kg in mice whereas only 2 mg/kg of this compound was effective in rats, when administered i.v. 15 min after pargyline treatment. Δ9-THC (50 mg/kg i.v.) delayed the depletion of neuronal HA in the mouse brain, as induced by treatment with a specific histidine decarboxylase inhibitor α-fluoromethylhistidine (50 mg/kg i.p.). Δ9-THC (30 and 100 μM) significantly inhibited the K+-induced release of endogenous HA from guinea-pig hypothalamic slices. These results suggest that Δ9-THC decreases HA turnover in the brain.

UR - http://www.scopus.com/inward/record.url?scp=0022005207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022005207&partnerID=8YFLogxK

M3 - Article

VL - 232

SP - 513

EP - 518

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -